Combination effect of oncolytic adenovirotherapy and TRAIL gene therapy in syngeneic murine breast cancer models (original) (raw)

• Anonymous. Recent trends in mortality rates for four major cancers by sex and race/ethnicity – United States 1990–1998. MMWR 2002; 51: 49–53.
• Seltzer V . Cancer in women: prevention and early detection. J Womens Health Gender Based Med 2000; 9: 483–488.
  Article CAS Google Scholar
• Fueyo J, Gomez-Manzano C, Alemany R, Lee PS, McDonnell TJ, Mitlianga P et al. A mutant oncolytic adenovirus targeting the Rb pathway produces anti-glioma effect in vivo. Oncogene 2000; 19: 2–12.
  Article CAS PubMed Google Scholar
• Fueyo J, Alemany R, Gomez-Manzano C, Fuller GN, Khan A, Conrad CA et al. Preclinical characterization of the antiglioma activity of a tropism-enhanced adenovirus targeted to the retinoblastoma pathway. J Natl Cancer Inst 2003; 95: 652–660.
  Article CAS PubMed Google Scholar
• Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S et al. Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter. Clin Cancer Res 2004; 10: 3535–3541.
  Article CAS PubMed Google Scholar
• Kagawa S, Gu J, Swisher SG, Ji L, Roth JA, Lai D et al. Antitumor effect of adenovirus-mediated Bax gene transfer on p53-sensitive and p53-resistant cancer lines. Cancer Res 2000; 60: 1157–1161.
  CAS PubMed Google Scholar
• Ginsberg HS, Moldawer LL, Sehgal PB, Redington M, Kilian PL, Chanock RM et al. A mouse model for investigating the molecular pathogenesis of adenovirus pneumonia. Proc Natl Acad Sci USA 1991; 88: 1651–1655.
  Article CAS PubMed PubMed Central Google Scholar
• Wang Y, Hallden G, Hill R, Anand A, Liu TC, Francis J et al. E3 gene manipulations affect oncolytic adenovirus activity in immunocompetent tumor models. Nat Biotechnol 2003; 21: 1328–1335.
  Article CAS PubMed Google Scholar
• Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA et al. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes. Cancer Res 2002; 62: 3620–3625.
  CAS PubMed Google Scholar
• Lin T, Huang X, Gu J, Zhang L, Roth JA, Xiong M et al. Long-term tumor-free survival from treatment with the GFP-TRAIL fusion gene expressed from the hTERT promoter in breast cancer cells. Oncogene 2002; 21: 8020–8028.
  Article CAS PubMed Google Scholar
• Kagawa S, He C, Gu J, Koch P, Rha SJ, Roth JA et al. Antitumor activity and bystander effects of the tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) gene. Cancer Res 2001; 61: 3330–3338.
  CAS PubMed Google Scholar
• Jiang H, Alemany R, Gomez-Manzano C, Alemany R, Medrano D, Alonso M et al. Comparative effect of oncolytic adenoviruses with E1A-55 kDa or E1B-55 kDa deletions in malignant gliomas. Neoplasia 2005; 1: 48–56.
  Article Google Scholar
• Hallden G, Hill R, Wang Y, Anand A, Liu TC, Lemoine NR et al. Novel immunocompetent murine tumor models for the assessment of replication-competent oncolytic adenovirus efficacy. Mol Ther 2003; 8: 412–424.
  Article CAS PubMed Google Scholar
• Zhu H, Zhang L, Huang X, Davis JJ, Jacob DA, Teraishi F et al. Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms. Mol Ther 2004; 9: 666–673.
  Article CAS PubMed Google Scholar
• Botos J, Smith III R, Kochevar DT . Retinoblastoma function is a better indicator of cellular phenotype in cultured breast adenocarcinoma cells than retinoblastoma expression. Exp Biol Med (Maywood) 2002; 227: 354–362.
  Article CAS Google Scholar
• Cheng L, Rossi F, Fang W, Mori T, Cobrinik D . Cdk2-dependent phosphorylation and functional inactivation of the pRB-related p130 protein in pRB(−), p16INK4A(+) tumor cells. J Biol Chem 2000; 39: 30317–30325.
  Article Google Scholar
• Chang YC, Illenye S, Heintz NH . Cooperation of E2F-p130 and Sp1-pRb complexes in repression of the Chinese hamster dhfr gene. Mol Cell Biol 2001; 4: 1121–1131.
  Article Google Scholar
• Hurford Jr RK, Cobrinik D, Lee MH, Dyson N . pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev 1997; 11: 1447–1463.
  Article CAS PubMed Google Scholar
• Burroughs KD, Kayda DB, Sakhuja K, Hudson Y, Jakubczak J, Bristol JA et al. Potentiation of oncolytic adenoviral vector efficacy with gutless vectors encoding GMCSF or TRAIL. Cancer Gene Ther 2004; 11: 92–102.
  Article CAS PubMed Google Scholar
• Pei Z, Chu L, Zou W, Zhang Z, Qiu S, Qi R et al. An oncolytic adenoviral vector of Smac increases antitumor activity of TRAIL against HCC in human cells and in mice. Hepatology 2004; 39: 1371–1381.
  Article CAS PubMed Google Scholar
• Sova P, Ren XW, Ni S, Bernt KM, Mi J, Kiviat N et al. A tumor-targeted and conditionally replicating oncolytic adenovirus vector expressing TRAIL for treatment of liver metastases. Mol Ther 2004; 9: 496–509.
  Article CAS PubMed Google Scholar
• Hiraga T, Ueda A, Tamura D, Hata K, Ikeda F, Williams PJ et al. Effects of oral UFT combined with or without zoledronic acid on bone metastasis in the 4T1/luc mouse breast cancer. Int J Cancer 2003; 106: 973–979.
  Article CAS PubMed Google Scholar
• Lee EY, To H, Shew JY, Bookstein R, Scully P, Lee WH . Inactivation of the retinoblastoma susceptibility gene in human breast cancers. Science 1988; 241: 218–221.
  Article CAS PubMed Google Scholar
• Harkes IC, Elstrodt F, Dinjens WN, Molier M, Klijn JG, Berns EM et al. Allelotype of 28 human breast cancer cell lines and xenografts. Br J Cancer 2003; 89: 2289–2292.
  Article CAS PubMed PubMed Central Google Scholar
• Padalecki SS, Guise TA . Actions of bisphosphonates in animal models of breast cancer. Breast Cancer Res 2002; 4: 35–41.
  Article CAS PubMed Google Scholar
• Yoneda T, Michigami T, Yi B, Williams PJ, Niewolna M, Hiraga T . Actions of bisphosphonate on bone metastasis in animal models of breast carcinoma. Cancer 2000; 88: 2979–2988.
  Article CAS PubMed Google Scholar